Medvi

Erin Griffith’s New York Times article of 2 Apr 2026 says Matthew Gallagher started Medvi, a telehealth provider of GLP-1 weight-loss drugs, with $20,000 and more than a dozen artificial intelligence tools. He used ChatGPT, Claude, and Grok to build the website, wrote custom agents so his software systems could talk to each other, tested ElevenLabs and other voice tools, and used Midjourney and Runway for images and video.

The lead says that in 2025, Medvi’s first full year, the company generated $401 million in sales, and that Gallagher and his brother Elliot are on track to do $1.8 billion in sales this year. Later the article says that by the end of last year Medvi had reached $401 million in annual sales and 250,000 customers, and that it produced 16.2 percent in net profit, or $65 million. The $1.8 billion line is “on track,” so it stays out of the figure cell.

The article also says Gallagher added two engineers on contract and hired Elliot. The live Times page returned 403 when this row was filed. The text above is from the Internet Archive snapshot of 3 Apr 2026. The article states the sales and profit figures. It does not, in the text this filing opened, say that the Times reviewed the company’s books, so this row is not payment-checked.